Mediphage Bioceuticals aims to leverage its DNA ministring platform for personalized genetic medicine. Mediphage Bioceuticals Inc. greatly appreciate Mitacs Accelerate program in providing support to (1) validate msDNA for gene delivery by carrying out a two-phase study, (2) develop and validate phage display libraries for the specific targeting and delivery to target host cells, and (3) determine potential targets for gene therapy in the treatment of Alzheimers disease with examination of potential negative effects of bacteriophage vector platforms. The research efforts in these key areas will enable Mediphage Bioceuticals to further advance genetic medicine.
Mediphage Bioceuticals Inc
Pharmacy / Pharmacology
Find the perfect opportunity to put your academic skills and knowledge into practice!Find Projects